种属 人
别称 A 2058; A-2058
组织来源 皮肤 ,来源于转移部位:淋巴结
疾-病 黑色素-瘤
传代比例/细胞消化 1:2传代 ,消化2-3分钟
完全培养基配置 DMEM培养基;10%胎牛血清;1%双抗
形态 上皮细胞样
生长特征 贴壁生长
倍增时间 每周 2 至 3 次
STR Amelogenin: X,Y CSF1PO: 10,11 D13S317: 13,14 D16S539: 9,13 D5S818: 9,12 D7S820: 11 TH01: 7,9
TPOX: 8 vWA: 14,18

mild irAEs, symptomatic care is usually suklicient. For higher grade irAEs, discontinuation of therapy and initiation of immunosuppressive therapy may be necessary. The managepknt of patients with irAEs involves multidisciplinary care coordination with respect to the long-term goals the individual patient. Clinicians must be aware of the unique and sopktipks fatal toxicologic